Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Peter Drückes
Introduction
Peter Drückes is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of chemical compound screening, particularly in the modulation of protein interactions. His work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Peter Drückes holds a patent for a process aimed at screening chemical compounds that modulate the interaction of an EVH1 domain. The patent, titled "Process for screening chemical compounds for modulating the interaction of an EVH1 domain and a process for detecting said interaction," focuses on identifying chemical compounds capable of influencing the interaction between VASP and zyxin. This innovative process involves bringing VASP or its derivatives into contact with chemical compounds and determining the effects using antibodies or fluorescent labels.
Career Highlights
Throughout his career, Peter Drückes has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Sanofi-Aventis Deutschland GmbH and Vasopharm Biotech GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of chemical interactions.
Collaborations
Peter has collaborated with several professionals in his field, including Birgit Jordan and Thomas Jarchau. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Peter Drückes exemplifies the spirit of innovation in the biotechnology sector through his patented processes and collaborations. His work continues to influence the understanding of protein interactions and their modulation.